Literature DB >> 2675756

Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro.

P K Rathod1, A Khatri, T Hubbert, W K Milhous.   

Abstract

Unlike mammalian cells, malarial parasites are completely dependent on de novo pyrimidine metabolism. Even though these parasites do not use external uracil or uridine, orotic acid, an intermediate of pyrimidine biosynthesis, is successfully transported into the parasite and incorporated into parasite nucleic acids. On this basis, it was hypothesized that 5-fluoroorotate, a cytotoxic derivative of orotic acid, may be a potent and selective antimalarial agent. In vitro, 5-fluoroorotate caused 50% inhibition of the growth of Plasmodium falciparum at a concentration of 6.0 nM. In contrast, 5-fluorouracil, 5-fluorouridine, and 5-fluoro 2'-deoxyuridine were much less effective against malarial parasites. Chloroquine-susceptible and chloroquine-resistant clones of P. falciparum were equally susceptible to 5-fluoroorotate. The toxicity of 5-fluoroorotate was evaluated on four human cell lines (HT-1080, IMR-90, HeLa S3, and HL-60) and one mouse cell line (L-1210). Compared with malarial parasites, the mammalian cells were relatively tolerant of 5-fluoroorotic acid (50% inhibitory concentration, 0.9 to 10 microM). Finally, in the presence of 1 mM uridine, all mammalian cells were partially protected from 5-fluoroorotate cytotoxicity, but uridine offered no protection to P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2675756      PMCID: PMC176067          DOI: 10.1128/AAC.33.7.1090

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  Conversion of dihydroorotate to orotate in parasitic protozoa.

Authors:  W E Gutteridge; D Dave; W H Richards
Journal:  Biochim Biophys Acta       Date:  1979-02-01

2.  Characterization of a newly derived human sarcoma cell line (HT-1080).

Authors:  S Rasheed; W A Nelson-Rees; E M Toth; P Arnstein; M B Gardner
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

3.  The synthesis of 5-fluorouridine 5'-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin. I. Some properties of the enzyme from P1534J mouse leukemic cells.

Authors:  P Reyes
Journal:  Biochemistry       Date:  1969-05       Impact factor: 3.162

4.  Purine and pyrimidine synthesis by the avian malaria parasite, Plasmodium lophurae.

Authors:  C J Walsh; I W Sherman
Journal:  J Protozool       Date:  1968-11

5.  The source of purines and pyrimidines in Plasmodium berghei.

Authors:  K Van Dyke; G C Tremblay; C H Lantz; C Szustkiewicz
Journal:  Am J Trop Med Hyg       Date:  1970-03       Impact factor: 2.345

6.  Biochemical strategy of the genome as expressed in regulation of pyrimidine metabolism.

Authors:  G Weber; T Shiotani; H Kizaki; D Tzeng; J C Williams; N Gladstone
Journal:  Adv Enzyme Regul       Date:  1977 Oct 3-4

7.  Purification of the bifunctional thymidylate synthase-dihydrofolate reductase complex from the human malaria parasite Plasmodium falciparum.

Authors:  G X Chen; J W Zolg
Journal:  Mol Pharmacol       Date:  1987-12       Impact factor: 4.436

8.  Salvage of circulating pyrimidine nucleosides by tissues of the mouse.

Authors:  J D Moyer; N Malinowski; O Ayers
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

9.  Pyrimidine de novo synthesis during the life cycle of the intraerythrocytic stage of Plasmodium falciparum.

Authors:  A M Gero; G V Brown; W J O'Sullivan
Journal:  J Parasitol       Date:  1984-08       Impact factor: 1.276

10.  Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro.

Authors:  D J Hammond; J R Burchell; M Pudney
Journal:  Mol Biochem Parasitol       Date:  1985-01       Impact factor: 1.759

View more
  29 in total

1.  Pyrophosphate interactions at the transition states of Plasmodium falciparum and human orotate phosphoribosyltransferases.

Authors:  Yong Zhang; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2010-06-30       Impact factor: 15.419

2.  Variations in frequencies of drug resistance in Plasmodium falciparum.

Authors:  P K Rathod; T McErlean; P C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 3.  Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.

Authors:  Margaret A Phillips; Pradipsinh K Rathod
Journal:  Infect Disord Drug Targets       Date:  2010-06

Review 4.  Purine and pyrimidine pathways as targets in Plasmodium falciparum.

Authors:  María Belén Cassera; Yong Zhang; Keith Z Hazleton; Vern L Schramm
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

5.  In vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolism.

Authors:  S A Queen; D L Jagt; P Reyes
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

6.  Transition state analogues of Plasmodium falciparum and human orotate phosphoribosyltransferases.

Authors:  Yong Zhang; Gary B Evans; Keith Clinch; Douglas R Crump; Lawrence D Harris; Richard F G Fröhlich; Peter C Tyler; Keith Z Hazleton; María B Cassera; Vern L Schramm
Journal:  J Biol Chem       Date:  2013-10-24       Impact factor: 5.157

7.  Frequency of drug resistance in Plasmodium falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance.

Authors:  S Gassis; P K Rathod
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

8.  Susceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase.

Authors:  P K Rathod; S Reshmi
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

9.  Selection and characterization of 5-fluoroorotate-resistant Plasmodium falciparum.

Authors:  P K Rathod; M Khosla; S Gassis; R D Young; C Lutz
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

10.  Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum.

Authors:  Margaret A Phillips; Ramesh Gujjar; Nicholas A Malmquist; John White; Farah El Mazouni; Jeffrey Baldwin; Pradipsinh K Rathod
Journal:  J Med Chem       Date:  2008-06-04       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.